Raymond Debbane

Board Member · Scholar Rock Holding Corp

Rank #251 SEC EDGAR (United States) ↗ Files from United States

Details

Member of the boardPharmaceuticals & BiotechnologySRRKSEC CIK 0001053890

Computed from SEC EDGAR filings and closing prices — not copied from any wealth ranking. Dataset . How we calculate this.

Disclosed holdings
$711.2M
1-day change
▼ 1.06%
Positions on file
2
issuers disclosed in Forms 3/4/5 and Schedules 13D/G

Disclosed holdings over time 53 weekly points

What the 2 currently disclosed positions would have been worth at each week’s closing price. A rising line means the shares got more valuable, not that this person bought more.

How the line is built

Share counts are as last reported to the SEC and held constant; only prices move.

2025-09-05$373.6M – $740.5M2026-09-04

Insider activity Apr 28, 2024 – Feb 25, 2026

Raymond Debbane is recorded in filings to the U.S. SEC via EDGAR as member of the board, and reported 29 transactions between Apr 28, 2024 and Feb 25, 2026. The buy and sell totals below count only codes P, S.

Why the other codes are excluded

Share awards (A), shares withheld to pay tax (F), option exercises (M) and gifts (G) also appear in the table, but they are consequences of a pay package or a private transfer, not a decision to buy or sell on the open market. Counting them would turn this into a compensation ranking.

Open-market buys (code P)
$2.72M
8 purchases on file priced rows only
Open-market sales (code S)
$82.89M
15 sales on file priced rows only
All reported transactions
29
every code, including awards and exercises
Pattern
Net buyer in the final 12 months of the window
last 12 months of the window

Events from filings

Detected automatically in the filings linked below. Each headline is built from the numbers in those filings, not written by a model. Newest first; events older than 45 days stay listed and are marked as older.

Raymond Debbane bought 1,538,462 LEXICON PHARMACEUTICALS, INC. (LXRX) shares for $2,000,001 on Feb 2, 2026

Large trade for this person

Flagged because this trade was large compared with this person’s own earlier open-market trades in the same currency — not because it is large in absolute terms. A trade that is routine for one insider can be flagged for another.

Raymond Debbane bought 1,538,462 LEXICON PHARMACEUTICALS, INC. (LXRX) shares for $2,000,001 on Feb 2, 2026
Date Insider Transaction Shares Price Value Filing
Feb 2, 2026 Raymond Debbane P Open-market purchase 1,538,462 held after: 1,538,462 $1.30 $2,000,001 SEC filing ↗

Source: SEC EDGAR (United States); every row links to where it was published. Event computed Sep 14, 2026.

Raymond Debbane sold 1,600,000 Scholar Rock Holding Corp (SRRK) shares for $66,640,000 on Dec 10, 2024

Large trade for this person

Flagged because this trade was large compared with this person’s own earlier open-market trades in the same currency — not because it is large in absolute terms. A trade that is routine for one insider can be flagged for another.

Raymond Debbane sold 1,600,000 Scholar Rock Holding Corp (SRRK) shares for $66,640,000 on Dec 10, 2024
Date Insider Transaction Shares Price Value Filing
Dec 10, 2024 Raymond Debbane S Open-market sale 1,600,000 held after: 9,250,005 $41.65 $66,640,000 SEC filing ↗

Source: SEC EDGAR (United States); every row links to where it was published. Event computed Sep 14, 2026.

Raymond Debbane sold 409,284 Scholar Rock Holding Corp (SRRK) shares for $15,751,192 on Nov 25, 2024

Large trade for this person

Flagged because this trade was large compared with this person’s own earlier open-market trades in the same currency — not because it is large in absolute terms. A trade that is routine for one insider can be flagged for another.

Raymond Debbane sold 409,284 Scholar Rock Holding Corp (SRRK) shares for $15,751,192 on Nov 25, 2024
Date Insider Transaction Shares Price Value Filing
Nov 25, 2024 Raymond Debbane S Open-market sale 208,272 held after: 11,051,166 $37.63 $7,837,275 SEC filing ↗
Nov 25, 2024 Raymond Debbane S Open-market sale 43,887 held after: 11,007,279 $38.43 $1,686,577 SEC filing ↗
Nov 25, 2024 Raymond Debbane S Open-market sale 126,442 held after: 10,880,837 $39.51 $4,995,723 SEC filing ↗
Nov 25, 2024 Raymond Debbane S Open-market sale 30,683 held after: 10,850,154 $40.14 $1,231,616 SEC filing ↗

Total of the rows above: $15,751,192, in the currency the filings report.

Source: SEC EDGAR (United States); every row links to where it was published. Event computed Sep 14, 2026.

Reported transactions

Price 0.00 is a real reported figure on gifts (G) and share awards (A) — not a missing number. The 21 most recent rows are grouped into 15 lines by date, company and transaction type — open a line to see every lot with its own source link.

How to read this list

Every row is one line of one Form 4 or Form 5, with the filing it came from. Where the record carries no price at all we leave the cell empty instead of guessing one.

The shares and money on a grouped line add up only the lots listed inside that line, and only when every one of them carries the figure. Where a group mixes more than one reporting currency we leave the money blank rather than convert — no source publishes the rate that conversion would need.

  1. LEXICON PHARMACEUTICALS, INC. LXRX M Option exercise or conversionnot a buy/sell decisionreported at zero 89,312 shares $0 at $0.00 SEC filing ↗
  2. LEXICON PHARMACEUTICALS, INC. LXRX P Open-market purchase 2,000 shares $3.0K at $1.49 SEC filing ↗
  3. LEXICON PHARMACEUTICALS, INC. LXRX P Open-market purchase 100,000 shares $147.0K at $1.47 SEC filing ↗
  4. LEXICON PHARMACEUTICALS, INC. LXRX P Open-market purchase 100,000 shares $148.0K at $1.48 SEC filing ↗
  5. LEXICON PHARMACEUTICALS, INC. LXRX P Open-market purchase 50,000 shares $72.0K at $1.44 SEC filing ↗
  6. LEXICON PHARMACEUTICALS, INC. LXRX P Open-market purchase 133,688 shares $176.5K at $1.32 SEC filing ↗
  7. LEXICON PHARMACEUTICALS, INC. LXRX P Open-market purchase 76,857 shares $100.7K at $1.31 SEC filing ↗
  8. LEXICON PHARMACEUTICALS, INC. LXRX P Open-market purchase 57,952 shares $75.9K at $1.31 SEC filing ↗
  9. LEXICON PHARMACEUTICALS, INC. LXRX A Grant or award × 3not a buy/sell decision 22,767,145 shares $52.98M
    The 3 lots that make up this line, each with the source behind it.
    Shares Price Value Filing
    367,145 $65.00 $23.86M SEC filing ↗
    18,553,846 $1.30 $24.12M SEC filing ↗
    3,846,154 $1.30 $5.00M SEC filing ↗
  10. LEXICON PHARMACEUTICALS, INC. LXRX P Open-market purchase 1,538,462 shares $2.00M at $1.30 SEC filing ↗
  11. Scholar Rock Holding Corp SRRK X In-the-money option exercisenot a buy/sell decision 1,575,008 shares $11.58M at $7.35 SEC filing ↗
  12. LEXICON PHARMACEUTICALS, INC. LXRX M Option exercise or conversionnot a buy/sell decisionreported at zero 36,810 shares $0 at $0.00 SEC filing ↗
  13. Scholar Rock Holding Corp SRRK S Open-market sale 1,600,000 shares $66.64M at $41.65 SEC filing ↗
  14. Scholar Rock Holding Corp SRRK S Open-market sale × 5 409,433 shares $15.76M
    The 5 lots that make up this line, each with the source behind it.
    Shares Price Value Filing
    30,683 $40.14 $1.23M SEC filing ↗
    149 $40.98 $6.1K SEC filing ↗
    126,442 $39.51 $5.00M SEC filing ↗
    43,887 $38.43 $1.69M SEC filing ↗
    208,272 $37.63 $7.84M SEC filing ↗
  15. LEXICON PHARMACEUTICALS, INC. LXRX M Option exercise or conversionnot a buy/sell decisionreported at zero 8,032 shares $0 at $0.00 SEC filing ↗

Disclosed holdings

Shares is the amount on the form; value is that amount times the closing price shown. Rows with no closing price are left blank, so they may add up to less than the headline figure.

What is not counted here

Each row is one filing you can open. Private companies, real estate, bonds and crypto are not in SEC insider filings and are therefore not counted here.

Equity positions disclosed to the SEC, with the source filing behind each row.
Issuer Ticker Security Shares Close Value Form Reported Filing
Scholar Rock Holding Corp SRRK Common Stock 10,825,013 $55.33 $598.9M 4 EDGAR ↗
LEXICON PHARMACEUTICALS, INC. LXRX Common Stock (indirect) 50,122,447 $2.24 $112.3M 4 EDGAR ↗

Other insiders at the same companies

People who also file with the SEC at a company where Raymond Debbane reports shares.

Sharing a filing does not mean they work together day to day — it means both names appear on the same issuer’s insider record.

Sources

The filings linked in the tables above are the sources for every figure on this page.

Think a number here is wrong? Open the linked filing and compare — how to report it.

Profile record last refreshed Sep 8, 2026.